History of Cancer Tied to Lower Endurance, Higher Fatigability

Share this content:
History of Cancer Tied to Lower Endurance, Higher Fatigability
History of Cancer Tied to Lower Endurance, Higher Fatigability

FRIDAY, March 23, 2018 (HealthDay News) -- A history of cancer is associated with fatigability and poor endurance, particularly in older adults, according to a study published recently in Cancer.

Gillian Gresham, Ph.D., from Johns Hopkins University in Baltimore, and colleagues assessed fatigability (Borg rating of perceived exertion scale after a five-minute, slow treadmill walk), endurance performance (ability and time to complete a fast-paced, 400-meter walk), and cancer history every two years among participants in the Baltimore Longitudinal Study of Aging (2007 to 2015).

The researchers found that 20 percent of participants (334 of 1,665) reported a history of cancer. Greater odds of high perceived fatigability and poor endurance were seen among participants who were >65 years old (odds ratio, 3.8) and with a history of cancer (odds ratio, 8.6; both P < 0.01). Among those who had a history of cancer, the median times to the development of high fatigability and poor endurance were shorter versus those who had no history of cancer (P < 0.01).

"The current findings suggest that a history of cancer is associated with fatigability and poor endurance and that this effect is significantly greater in older adults," the authors write. "Evaluating the effects of cancer and age on fatigability may illuminate potential pathways and targets for future interventions."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths